trending Market Intelligence /marketintelligence/en/news-insights/trending/c991gqkz9fee8t4sskh4pg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Antibe Therapeutics completes private placement, raises C$2.7M

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


Antibe Therapeutics completes private placement, raises C$2.7M

Antibe Therapeutics Inc. completed the second and final closing of its private placement, raising another C$297,750 in gross proceeds to bolster the C$2.4 million raised in the first tranche of the offering.

The net proceeds of approximately C$2.7 million will be used for clinical development and general purposes.

The issued securities are subject to a four-month statutory hold period and a TSX Venture Exchange hold period, each expiring April 22, 2017.